Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells

被引:231
作者
Deuse, Tobias [2 ,3 ,7 ]
Stubbendorff, Mandy [2 ]
Tang-Quan, Karis [2 ,3 ]
Phillips, Neil [4 ]
Kay, Mark A. [4 ]
Eiermann, Thomas [5 ]
Phan, Thang T. [6 ]
Volk, Hans-Dieter [8 ]
Reichenspurner, Hermann [2 ,7 ]
Robbins, Robert C. [3 ]
Schrepfer, Sonja [1 ,2 ,3 ,7 ]
机构
[1] Univ Heart Ctr Hamburg, Transplant & Stem Cell Immunobiol Lab, D-20146 Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Cardiovasc Res Ctr, TSI Lab, Hamburg, Germany
[3] Stanford Univ, Sch Med, Standord, CA USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[5] Univ Hosp Hamburg Eppendorf, HLA Lab, Hamburg, Germany
[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore
[7] CellResearchCorp, Clin Res Ctr, Singapore, Singapore
[8] Campus Virchow Klinikum, BCRT, Berlin, Germany
关键词
Mesenchymal stem cells (MSCs); Immunogenicity; Immunomodulation; Stem cell transplantation; MARROW STROMAL CELLS; T-LYMPHOCYTE PROLIFERATION; INTERFERON-GAMMA; PROGENITOR CELLS; ADIPOSE-TISSUE; TGF-BETA; INHIBIT; SURVIVAL; THERAPY; HOST;
D O I
10.3727/096368910X536473
中图分类号
Q813 [细胞工程];
学科分类号
摘要
We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients > 65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-beta and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-gamma at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-beta and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-gamma (> 50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-gamma environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.
引用
收藏
页码:655 / 667
页数:13
相关论文
共 51 条
[1]   Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].
Augello, A ;
Tasso, R ;
Negrini, SM ;
Amateis, A ;
Indiveri, F ;
Cancedda, R ;
Pennesi, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490
[2]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[3]   Mesenchymal Stem Cells in the Induction of Transplantation Tolerance [J].
Bartholomew, Amelia ;
Polchert, David ;
Szilagyi, Erzsebet ;
Douglas, G. W. ;
Kenyon, Norma .
TRANSPLANTATION, 2009, 87 (09) :S55-S57
[4]   Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].
Campagnoli, C ;
Roberts, IAG ;
Kumar, S ;
Bennett, PR ;
Bellantuono, I ;
Fisk, NM .
BLOOD, 2001, 98 (08) :2396-2402
[5]   In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery [J].
Cao, F ;
Lin, S ;
Xie, XY ;
Ray, P ;
Patel, M ;
Zhang, XZ ;
Drukker, M ;
Dylla, SJ ;
Connolly, AJ ;
Chen, XY ;
Weissman, IL ;
Gambhir, SS ;
Wu, JC .
CIRCULATION, 2006, 113 (07) :1005-1014
[6]   Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ [J].
Chan, Jennifer L. ;
Tang, Katherine C. ;
Patel, Anoop P. ;
Bonilla, Larissa M. ;
Pierobon, Nicola ;
Ponzio, Nicholas M. ;
Rameshwar, Pranela .
BLOOD, 2006, 107 (12) :4817-4824
[7]   Human mesenchymal stem cells modulate B-cell functions [J].
Corcione, A ;
Benvenuto, F ;
Ferretti, E ;
Giunti, D ;
Cappiello, V ;
Cazzanti, F ;
Risso, M ;
Gualandi, F ;
Mancardi, GL ;
Pistoia, V ;
Uccelli, A .
BLOOD, 2006, 107 (01) :367-372
[8]   Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group [J].
Dahlke, Marc H. ;
Hoogduijn, Martin ;
Eggenhofer, Elke ;
Popp, Felix C. ;
Renner, Philipp ;
Slowik, Przemyslaw ;
Rosenauer, Agnes ;
Piso, Pompiliu ;
Geissler, Edward K. ;
Lange, Claudia ;
Chabannes, Dominique ;
Mazzanti, Benedetta ;
Bigenzahn, Sinda ;
Bertolino, Patrick ;
Kunter, Uta ;
Introna, Martino ;
Rambaldi, Alessandro ;
Capelli, Chiara ;
Perico, Norberto ;
Casiraghi, Federica ;
Noris, Marina ;
Gotti, Eliana ;
Seifert, Martina ;
Saccardi, Riccardo ;
Verspaget, Hein W. ;
van Hoek, Bart ;
Bartholomew, Amelia ;
Wekerle, Thomas ;
Volk, Hans D. ;
Remuzzi, Giuseppe ;
Deans, Robert ;
Lazarus, Hillard ;
Schlitt, Hans J. ;
Baan, Carla C. .
TRANSPLANTATION, 2009, 88 (05) :614-619
[9]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[10]   SSEA-4 identifies mesenchymal stem cells from bone marrow [J].
Gang, Eun J. ;
Bosnakovski, Darko ;
Figueiredo, Camila A. ;
Visser, Jan W. ;
Perlingeiro, Rita C. R. .
BLOOD, 2007, 109 (04) :1743-1751